Ratings Pacific Smiles Group Limited

Equities

PSQ

AU000000PSQ9

Delayed Australian S.E. 01:54:46 2024-05-03 am EDT 5-day change 1st Jan Change
1.89 AUD -0.53% Intraday chart for Pacific Smiles Group Limited +15.24% +29.45%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The company is in a robust financial situation considering its net cash and margin position.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • The company sustains low margins.
  • With an expected P/E ratio at 46.38 and 37.71 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+29.45% 198M -
+14.10% 81.68B
C+
-30.15% 69.23B
B-
+9.37% 29.08B
C+
-11.90% 16.88B
B
-0.36% 16.85B
A-
-1.12% 15.15B
A-
+5.90% 12.62B
A-
+35.78% 12.47B
B-
-4.20% 11.66B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PSQ Stock
  4. Ratings Pacific Smiles Group Limited